arcadia biosciences glp-1 receptor agonist weight management diabetes treatments Frontiers GLP-1-based therapies for diabetes, obesity
Description
The Diabetes Control and Complications Trial Research Group
Medication name
Mechanism of Action Comparison# Retatrutide# Retatrutide is a single-molecule triple agonist that simultaneously activates three receptors: GIP receptor (GIPR), GLP-1 receptor (GLP-1R), and glucagon receptor (GCGR)
Because this action is glucose-dependent, it can help to prevent hypoglycemia
